Curaleaf Holdings, Inc. (CURA.TO)

CAD 1.31

(-2.24%)

Net Debt Summary of Curaleaf Holdings, Inc.

  • Curaleaf Holdings, Inc.'s latest annual net debt in 2023 was 1.32 Billion USD , down -0.51% from previous year.
  • Curaleaf Holdings, Inc.'s latest quarterly net debt in 2024 Q1 was 1.32 Billion USD , down -2.23% from previous quarter.
  • Curaleaf Holdings, Inc. reported annual net debt of 1.33 Billion USD in 2022, up 106.73% from previous year.
  • Curaleaf Holdings, Inc. reported annual net debt of 645.22 Million USD in 2021, up 0.45% from previous year.
  • Curaleaf Holdings, Inc. reported quarterly net debt of 765.42 Million USD for 2024 Q2, down -21.81% from previous quarter.
  • Curaleaf Holdings, Inc. reported quarterly net debt of 1.32 Billion USD for 2023 FY, down -0.51% from previous quarter.

Annual Net Debt Chart of Curaleaf Holdings, Inc. (2023 - 2016)

Created with Highcharts 11.1.0YearsNet Debt20162017201820192020202120222023-500000000 CAD0 CAD500000000 CAD1000000000 CAD1500000000 CAD

Historical Annual Net Debt of Curaleaf Holdings, Inc. (2023 - 2016)

Year Net Debt Net Debt Growth
2023 1.32 Billion USD -0.51%
2022 1.33 Billion USD 106.73%
2021 645.22 Million USD 0.45%
2020 642.3 Million USD 217.93%
2019 202.02 Million CAD 181.14%
2018 -249 Million CAD -1743.36%
2017 -13.5 Million CAD -45201.68%
2016 -29.81 Thousand CAD 0.0%

Peer Net Debt Comparison of Curaleaf Holdings, Inc.

Name Net Debt Net Debt Difference
Aurora Cannabis Inc. -8.64 Million CAD 15445.055%
Avicanna Inc. 1.32 Million CAD -99963.441%
Avant Brands Inc. 17.93 Million CAD -7301.229%
Cardiol Therapeutics Inc. -34.77 Million CAD 3916.268%
Crescita Therapeutics Inc. -8.13 Million CAD 16420.752%
Knight Therapeutics Inc. 10.33 Million CAD -12746.47%
MediPharm Labs Corp. -15.68 Million CAD 8560.03%
OrganiGram Holdings Inc. -33.7 Million CAD 4036.754%
Canopy Growth Corporation 512.87 Million CAD -158.747%
Willow Biosciences Inc. -989 Thousand CAD 134280.016%
Auxly Cannabis Group Inc. 142.88 Million CAD -828.78%